Company Filing History:
Years Active: 2006-2013
Title: Innovations in Therapeutic Delivery: The Contributions of Brian Ernest Mann
Introduction
Brian Ernest Mann, an accomplished inventor based in Sheffield, GB, has made significant strides in the field of pharmaceutical innovations. With a total of four patents to his name, his work primarily focuses on the therapeutic delivery of carbon monoxide using advanced metal carbonyl compounds. His research holds potential implications for medical treatments and therapies.
Latest Patents
Mann's latest patents revolve around the therapeutic delivery of carbon monoxide. One of his notable inventions involves pharmaceutical compositions and methods that utilize transition metal complexes containing substituted cyclopentadienyl, indenyl, or fluorenyl ligands coupled with carbonyl ligands. This patent highlights the use of metal carbonyls in delivering biologically active carbon monoxide, which can induce vasodilatation and inhibit transplant rejection. In these compositions, the metal from the carbonyl typically belongs to groups 7 to 10 of the periodic table, such as Iron (Fe) and Ruthenium (Ru). The inclusion of other ligands, such as amine acids, helps to modulate the carbon monoxide release property and enhance solubility.
Career Highlights
Brian Ernest Mann's career has been marked by his dedication to innovative research and a pursuit of developing groundbreaking therapeutic methods. His position at Hemocorm Limited enables him to explore and advance his ideas in a professional environment, contributing to the company's mission of delivering novel treatment solutions. His work has drawn attention within the scientific community, particularly in the pharmaceutical sector.
Collaborations
Throughout his career, Mann has collaborated with fellow researchers and innovators, including Roberto Angelo Motterlini and Tony Richard Johnson. These collaborations have allowed for an exchange of ideas and the fusion of expertise, further enhancing the impact of their collective work in the field of medicinal chemistry and therapy development.
Conclusion
In conclusion, Brian Ernest Mann's innovative contributions to the therapeutic delivery of carbon monoxide present significant opportunities for advancements in medical treatments. His inventive work continues to pave the way for new pharmaceutical applications, demonstrating the vital role of inventors in the evolution of healthcare solutions. With the support of collaborators and his affiliation with Hemocorm Limited, Mann is poised to make further contributions to the field of therapeutic innovation.